HBF Vaccine Watch
| NAME | TYPE VACCINE | COMPANY | STATUS |
|---|---|---|---|
| Hepatitis B Vaccines - Recommended for those at risk and patients with chronic HCV | |||
| Engerix B | Recombinant HBV | GlaxoSmithKline, Philadelphia, PA | Market, USA |
| Recombivax HB | Recombinant HBV | Merck, West Point, PA | Market, USA |
| Gen Hevac B | Recombinant HBV | Aventis Pasteur, Lyons, France | Market, Europe |
| Hepacare (formerly, Hepagene) |
HBV preS1, preS2 | PowderJect, Oxford, U.K. | Market, Europe |
| Bio-Hep B | HBV S, preS1, PreS2 | Biotech. Gen. Corp., Iselin, N.J. | Market, Israel |
| Hepavax Gene | Recombinant HBV | Berna Biotech, Switzerland | Market, Europe |
| Hepatitis A Vaccines - Recommended for those at risk and patients with chronic HBV and HCV | |||
| Havrix | Inactivated HAV | GlaxoSmithKline | Market, USA |
| VAQTA | Inactivated HAV | Merck | Market, USA |
| Avaxim | Inactivated HAV | Aventis Pasteur | Market, Europe |
| Combination Hepatitis Vaccines | |||
| TwinRix (Adult) | HBV and HAV | GlaxoSmithKline | Market, USA |
| Comvax (Pediatric) | HBV and HiB | Merck | Market, USA |
| Pediarix (Pediatric) | HBV, Polio, DTP | GlaxoSmithKline | Market, USA |
| Hexavac (Pediatric) | HBV, DTP, HiB, Polio | Aventis Pasteur | Market, Europe |
| Hepatitis Vaccines in Development | |||
| Extra Strength Hep B (for poor or nonresponders) |
Recombinant | GlaxoSmithKline (with Corixa) |
Phase III |
| Heplisav | ISS-linked to HBsAg | Dynavax Technology, Berkley, CA | Phase III |
| Hep B DNA Vaccine Px |
HBV DNA Vaccine | PowderJect | Phase I |
Page last modified February 23, 2012
